2-氟-4-羟基苯甲酸甲酯 | 197507-22-5

• 物质功能分类: 化学试剂 - 有机试剂 - 酯类
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氟-4-羟基苯甲酸甲酯
• 英文名称: methyl 2-fluoro-4-hydroxybenzoate
• CAS: 197507-22-5
• 化学式: C₈H₇FO₃
• 分子量: 170.14
• InChiKey: WYSPMXSNCAFCFV-UHFFFAOYSA-N

物化性质

• 沸点：
  287℃
• 密度：
  1.309
• 闪点：
  127℃

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 海关编码：
  2918290000
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  | 2-8°C |

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Methyl 2-fluoro-4-hydroxybenzoate
Product Name:
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
Methyl 2-fluoro-4-hydroxybenzoate
Ingredient name:
CAS number: 197507-22-5

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C8H7FO3
Molecular weight: 170.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

2-氟-4-羟基苯甲酸甲酯可用作医药合成中间体。其制备过程可以通过以下步骤实现：首先，将2-氟-4-甲氧基苯甲醛在溴及氢氧化钠的作用下生成2-氟-4-甲氧基苯甲酸；接着，通过脱去甲基得到2-氟-4-羟基苯甲酸；最后，与甲醇反应形成酯，从而制备出2-氟-4-羟基苯甲酸甲酯。

反应信息

• 作为反应物：
  描述：

  2-氟-4-羟基苯甲酸甲酯 在 palladium on activated charcoal 、 N,N-二甲基甲酰胺 吗啉 、 草酰氯 、 水 、 氢气 、 三乙胺 、 三苯基膦 、 sodium hydroxide 、 偶氮二甲酸二乙酯 作用下， 以 四氢呋喃 、 甲醇 、 异丁酰胺 、 甲苯 、 正丁醇 为溶剂， 反应 52.0h， 生成 2-fluoro-N-(3-formyl-8-methylquinolin-7-yl)-4-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide
  参考文献：
  名称：

  EP2392573

  摘要：

  公开号：
• 作为产物：
  描述：

  2-氟-4-溴苯甲酸甲酯 在 甲酸 、 氧气 、 三乙胺 、 copper(ll) bromide 作用下， 以 乙腈 为溶剂， 反应 48.0h， 以45%的产率得到2-氟-4-羟基苯甲酸甲酯
  参考文献：
  名称：

  （杂）芳基卤化物与分子氧的协同光催化铜羟基化反应

  摘要：

  在室温下用O 2光氧化还原介导的铜催化（杂）芳基卤化物（包括氯化物，溴化物和碘化物）的铜催化羟基化作用。初步的机理研究表明，没有芳基铜中间体，并且芳基自由基也参与了该程序。18个O标记实验证实了羟基氧原子起源于分子氧。

  DOI：

  10.1021/acs.orglett.7b03840

文献信息

• Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
  申请人：Hormann Eugene Robert

  公开号：US20060020146A1

  公开（公告）日：2006-01-26

  The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.

  本发明涉及用于核受体基于诱导基因表达系统的非甾体配体，以及一种调节外源基因表达的方法，其中包括一个包含：DNA结合结构域；配体结合结构域；转活化结构域；和配体的ecdysone受体复合物与包含外源基因和响应元件的DNA构建物接触；其中外源基因受响应元件控制，并且在配体存在的情况下DNA结合结构域与响应元件结合导致基因的激活或抑制。
• Benzamide derivatives and their constrained analogs as histamine H 3 receptor antagonists
  作者：Ramakrishna Nirogi、Anil Shinde、Vinaykumar Tiriveedhi、Laxman Kota、Sangram Keshari Saraf、Rajesh Kumar Badange、Abdul Rasheed Mohammed、Ramkumar Subramanian、Nageshwararao Muddana、Gopinadh Bhyrapuneni、Renny Abraham

  DOI：10.1016/j.ejmech.2015.12.005

  日期：2016.1

  A series of 4-(1-substituted piperidin-4-yloxy) benzamides and 6-(1-substituted piperidin-4-yloxy)-3,4-dihydro-2H-isoquinolin-1-one derivatives have been synthesized and tested for their binding affinity towards H3 receptor. Most of these synthesized compounds have displayed potent binding affinity for H3 receptor when tested in in vitro binding assay. Preliminary SAR studies, functional activity,

  合成了一系列的4-（1-取代的哌啶-4-基氧基）苯甲酰胺和6-（1-取代的哌啶-4-基氧基）-3,4-二氢-2H-异喹啉-1-酮衍生物，并对其进行了测试。它们对H 3受体的结合亲和力。当在体外结合试验中测试时，这些合成的化合物中的大多数已显示出对H 3受体的有效结合亲和力。SAR的初步研究，功能活性，药代动力学特征和功效特征构成了本通报的主题。
• [EN] MORPHOLINE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS<br/>[FR] AMIDES DE PIPÉRIDINE SPIROCYCLIQUES MORPHOLINES UTILISÉS EN TANT QUE MODULATEURS DE CANAUX IONIQUES
  申请人：VERTEX PHARMA

  公开号：WO2012125613A1

  公开（公告）日：2012-09-20

  The invention relates to morpholine spirocyclic piperidine amide compounds useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

  这项发明涉及吗啡啶螺环哌啶酰胺化合物，可用作离子通道抑制剂。该发明还提供了包括该发明化合物的药用可接受组合物，以及使用这些组合物治疗各种疾病的方法。
• BROMODOMAIN INHIBITORS
  申请人：Quanticel Pharmaceuticals

  公开号：US20150111885A1

  公开（公告）日：2015-04-23

  The present invention relates to substituted heterocyclic derivative compounds, compositions comprising said compounds, and the use of said compounds and compositions for epigenetic regulation by inhibition of bromodomain-mediated recognition of acetyl lysine regions of proteins, such as histones. Said compositions and methods are useful for the treatment of cancer and neoplastic disease.

  本发明涉及替代杂环衍生物化合物，包括所述化合物的组合物，以及通过抑制溴结构域介导的蛋白质乙酰赖氨酸区域的识别来进行表观遗传调控的所述化合物和组合物的用途。所述组合物和方法对于癌症和肿瘤性疾病的治疗是有用的。
• [EN] CONFORMATIONALLY CONSTRAINED CARBOXYLIC ACID DERIVATIVES USEFUL FOR TREATING METABOLIC DISORDERS<br/>[FR] DÉRIVÉS D'ACIDE CARBOXYLIQUE CONFORMATIONNELLEMENT DÉPENDANTS, UTILES DANS LE TRAITEMENT DE TROUBLES DU MÉTABOLISME
  申请人：AMGEN INC

  公开号：WO2009111056A1

  公开（公告）日：2009-09-11

  The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I or the general formula III: where the definitions of the variables are provided herein. The present invention also provides compositions that include, and methods for using, the compounds in preparing medicaments and for treating metabolic disorders such as, for example, type II diabetes.

  本发明提供了用于治疗主体内的代谢紊乱的化合物，例如，II型糖尿病。这些化合物具有通用公式I或通用公式III：其中变量的定义如下。本发明还提供了包括这些化合物的组合物，以及用于制备药物和治疗代谢紊乱如II型糖尿病的方法。